Niell H B, Mickey D D, Soloway M S, Wood C A
Cancer. 1982 Jan 15;49(2):323-30. doi: 10.1002/1097-0142(19820115)49:2<323::aid-cncr2820490219>3.0.co;2-b.
Four N-[4-(5-nitro-2-furyl)-2-thiazolyl]-Formamide (FANFT)-induced mouse bladder tumor (MBT) lines were tested for their ability to form colonies in a tumor stem cell assay. Anticancer drug testing was done using this assay to determine whether reproducible colony survival curves could be be produced. All four cell lines produced colonies at 10--14 days, whether taken from culture or murine tumor. Cloning efficiencies ranged from 0.29% to 1.93% from culture and from 0.005% to 0.05% from the murine source. Growth characteristics were described. Cells from colonies were histologically similar to the original cells plated. A linear relationship existed between the number of cells plated and the number of colonies produced. In vitro drug studies were reproducible and correlated with in vivo data. Therefore, MBT lines can be used for in vitro drug testing in a tumor stem cell assay and may be useful in selecting active chemotherapeutic agents in the murine tumor model.
对四种N-[4-(5-硝基-2-呋喃基)-2-噻唑基]-甲酰胺(FANFT)诱导的小鼠膀胱肿瘤(MBT)细胞系进行了肿瘤干细胞检测,以评估它们形成集落的能力。利用该检测方法进行抗癌药物测试,以确定是否能够生成可重复的集落存活曲线。所有四种细胞系在10 - 14天内均形成了集落,无论其来源于培养物还是小鼠肿瘤。克隆效率在培养物中为0.29%至1.93%,在小鼠来源中为0.005%至0.05%。描述了生长特性。集落中的细胞在组织学上与最初接种的细胞相似。接种的细胞数量与产生的集落数量之间存在线性关系。体外药物研究具有可重复性,且与体内数据相关。因此,MBT细胞系可用于肿瘤干细胞检测中的体外药物测试,在小鼠肿瘤模型中选择活性化疗药物时可能有用。